Tepezza Medication Linked with Potential Increased Risk of Hearing Loss
Thyroid eye disease medication Tepezza (teprotumumab) has recently been linked to an increase in hearing loss and other hearing problems like tinnitus. The first Tepezza lawsuit was filed in August 2022 and more are expected to follow. Patients claim that manufacturer Horizon Pharmaceuticals failed to…